The company, established in Malaysia, primarily invests in healthcare and biotechnology startups that are 6-10 years old. They typically invest in rounds with 1-2 participants and have a track record of exiting investments more frequently than other organizations. The fund typically invests in deals ranging from $10-50 million and is involved in less than 2 deals per year. Their top activity was in 2013. Despite being based in Malaysia, the company's most frequent investments are in the United States. Some of their notable portfolio startups include Applied Proteomics.